Tips for Navigating COVID-19 in the Winter: Stay Vigilant. Stay Safe.
In a special video, Mass General's Rochelle Walensky, MD, MPH, addresses common questions about navigating COVID-19 during the winter months.
Safe Care CommitmentGet the care you need even during COVID-19.Learn more
Dr. Rochelle Walensky, MD, MPH, is Professor of Medicine at Harvard Medical School and a practicing Infectious Disease physician at Massachusetts General Hospital and Brigham and Women's Hospital.
Dr. Walensky's research interests focus on model-based analyses of the cost-effectiveness of HIV testing, care, and prevention strategies to inform HIV/AIDS policy internationally and domestically.
Using both traditional novel methods of microsimulation modeling and decision analysis, Dr. Walensky has been active in and nationally recognized for motivating health policy and informing clinical trial design and evaluation in a variety of settings.
In addition, Dr. Walensky has been influential in advancing international health policy towards the promotion of HIV treatment as prevention (TasP) and the adoption of other effective and efficient strategies of HIV care.
Dr. Walensky serves as Chair of the Office of AIDS Research Advisory Council (NIH) and as a member of the US Department of Health and Human Services Panel on Antiretroviral Guidelines for Adults and Adolescents.
Clinical Interests:
Treats:
Infectious Disease Associates
55 Fruit Street
Boston, MA 02114-2696
Phone: 617-724-3467
Medical Education
American Board Certifications
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
Rochelle Walensky, MD, MPH, is the Chief of Infectious Diseases at MGH and Professor of Medicine at Harvard Medical School. Dr. Walensky’s research interests have focused on HIV/AIDS policy and cost-effective strategies of HIV care in the US and in resource-limited settings; she is internationally recognized for motivating US and global policy toward routine HIV screening. She is a member of the American Society for Clinical Investigation, the American Association of Physicians, and the DHHS Panel on Antiretroviral Guidelines for Adults and Adolescents, and she is past Chair of the NIH Office of AIDS Research Advisory Council. She has also been an advisor to the WHO and UNAIDS. Dr. Walensky received her M.D. from the Johns Hopkins School of Medicine and her M.P.H. from the Harvard School of Public Health. She trained in Internal Medicine at the Johns Hopkins Hospital and in Infectious Diseases at the MGH/BWH combined fellowship program.
View my most recent publications at PubMed
Selected References:
Secure online access to your health information whenever you need it. Check appointments, communicate with your provider and pay bills online 24/7.
Mass General is the #1 Research Hospital in America and the only hospital to be recognized in all 16 specialties assessed by U.S. News & World Report.
President-elect Joe Biden has appointed Mass General’s Dr. Rochelle Walensky to serve as director of the Centers for Disease Control and Prevention.
Dr. Walensky discusses how she has worked to help expand access to care for HIV patients.
In a special video, Mass General's Rochelle Walensky, MD, MPH, addresses common questions about navigating COVID-19 during the winter months.
Dr. Walensky has been nominated to serve as director of the U.S. Centers for Disease Control and Prevention by President-elect Joseph Biden.
The success of a COVID-19 vaccine will depend not only on its efficacy, but will hinge at least as much on how fast and widely it can be delivered, the severity of the pandemic, and the public’s willingness to be immunized, according to a study published in Health Affairs.
In this episode of the Charged podcast, Dr. Walensky discusses how she has worked to help expand access to care for HIV patients, through her research and her willingness to understand patients’ struggles.
在此视频中,美国麻省总医院医学中心主任Paul Biddinger医师和传染病科主任医师Rochelle Walensky医师回答了有关新型冠状病毒的常见问题,以进一步阐明病毒的性质以及如何保护自己和亲人。
随着新型冠状病毒在美国的感染人数增速逐渐放缓,医学专家们与政府决策人员开始考虑对今年下半年的预期以及恢复日常生活所需的措施。